Dacogen
Term · Oncology and biomedicine · MLC-T-ONC-002267
A drug used to treat adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Dacogen stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called decitabine.
| Identifier | MLC-T-ONC-002267 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | decitabine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002267",
"term": "Dacogen",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Dacogen stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called decitabine.",
"synonyms": [
"decitabine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/dacogen/"
}
Record 5,656 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.